Morning Headlines 6/19/24
Google’s Verily to offer GLP-1 drugs through Lightpath, its retooled chronic care app
Alphabet’s Verily will reportedly pivot – for the second time in two years – by retiring its chronic disease management app Onduo and moving to a new one called Lightpath, which will focus on AI-sprinkled diabetes treatment and issuing prescriptions for GLP-1 drugs.
Home care management solutions vendor HHAeXchange acquires Cashé Software, which offers homecare operations and billing software.
Talkiatry Secures $130M Series C Funding to Mainstream Value-Based Behavioral Health Care
Telepsychiatry services provider Talkiatry raises $130 million in a Series C funding round, bringing its total raised to $245 million.
Weird that Google can acknowledge its crowdsourced medical advice was wrong, but escape penalties for doing it wantonly at scale.